DBD vs CXM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 18, 2026
DBD
CXM
Investment Advisor Scores
CXM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DBD | CXM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 12.1655 | 20.7039 | DBD |
| PEG Ratio | 0 | 0.824 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.7% | 0.8% | DBD |
| Earnings Growth | 34.2% | -39.5% | DBD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.5/100 | 43.8/100 | CXM |
| Profit Margin | 2.9% | 2.6% | DBD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | CXM |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DBD
NeutralMixed signals - no dominant trend phase, RSI 60
CXM
NeutralMixed signals - no dominant trend phase, RSI 68
Fundamentals Snapshot
| Metric | DBD | CXM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.7 | 13.5 |
| Trailing P/E | 22.4 | 71.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.0% |
| Gross Margin | 0.3% | 0.7% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 3.03 | 0.09 |
| Dividend Yield | — | — |